Page last updated: 2024-11-06

trefentanil

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth

Description

trefentanil: RN refers to hydrochloride; a short-acting analgesic [Medical Subject Headings (MeSH), National Library of Medicine, extracted Dec-2023]

Cross-References

ID SourceID
PubMed CID60728
CHEMBL ID84617
SCHEMBL ID397177
MeSH IDM0215069

Synonyms (19)

Synonym
trefentanyl
CHEMBL84617
a-3665 ,
trefentanil
n-[1-[2-(4-ethyl-5-oxotetrazol-1-yl)ethyl]-4-phenylpiperidin-4-yl]-n-(2-fluorophenyl)propanamide
L001379
unii-36qm58lvgu
120656-74-8
36qm58lvgu ,
trefentanil [inn]
trefentanil [who-dd]
n-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1h-tetrazol-1-yl)ethyl)-4-phenyl-4-piperidinyl)-n-(2-fluorophenyl)propanamide
trefentanil [mart.]
propanamide, n-(1-(2-(4-ethyl-4,5-dihydro-5-oxo-1h-tetrazol-1-yl)ethyl)-4-phenyl-4-piperidinyl)-n-(2-fluorophenyl)-
a-3665 free base
SCHEMBL397177
DTXSID80152955
DB09181
Q7837766

Research Excerpts

Dosage Studied

We determined the possible benefits of a new opioid, trefentanil, relative to fentanyl and alfent anil using high-resolution pharmacokinetic-pharmacodynamic modeling and computer simulations of clinical dosing scenarios. Finally, we used computer simulations to predict offset of opioid effects of trefenil, fentanyl, and alFENTanil when given in different dosing schemes.

ExcerptRelevanceReference
"We determined the possible benefits of a new opioid, trefentanil, relative to fentanyl and alfentanil using high-resolution pharmacokinetic-pharmacodynamic modeling and computer simulations of clinical dosing scenarios."( Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil.
Dyck, JB; Lemmens, HJ; Shafer, SL; Stanski, DR, 1994
)
0.29
" Finally, we used computer simulations to predict offset of opioid effects of trefentanil, fentanyl, and alfentanil when given in different dosing schemes."( Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil.
Dyck, JB; Lemmens, HJ; Shafer, SL; Stanski, DR, 1994
)
0.29
"We suggest that high-resolution pharmacokinetic-pharmacodynamic studies and computer simulations of clinical dosing scenarios may have significant usefulness in appreciating differences between new and established drugs in early phase I studies."( Pharmacokinetic-pharmacodynamic modeling in drug development: application to the investigational opioid trefentanil.
Dyck, JB; Lemmens, HJ; Shafer, SL; Stanski, DR, 1994
)
0.29
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Bioassays (4)

Assay IDTitleYearJournalArticle
AID114189Analgesic activity in nonfasted male mice at 55 degree C using Hot plate assay1989Journal of medicinal chemistry, Dec, Volume: 32, Issue:12
4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents.
AID178398Effective dose for its analgesic activity in male Sprague-Dawley rats using rat hot plate assay1989Journal of medicinal chemistry, Dec, Volume: 32, Issue:12
4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents.
AID189328Analgesic activity was determined by observing the recovery of motor coordination in rats1989Journal of medicinal chemistry, Dec, Volume: 32, Issue:12
4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents.
AID178021Effective dose for analgesic activity in male Sprague-Dawley rats using tail flick method1989Journal of medicinal chemistry, Dec, Volume: 32, Issue:12
4-Phenyl- and 4-heteroaryl-4-anilidopiperidines. A novel class of analgesic and anesthetic agents.
[information is prepared from bioassay data collected from National Library of Medicine (NLM), extracted Dec-2023]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19901 (20.00)18.7374
1990's3 (60.00)18.2507
2000's1 (20.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials2 (40.00%)5.53%
Reviews1 (20.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other2 (40.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]